NEW YORK--(BUSINESS WIRE)--Feb. 23, 2006--Bioenvision (NASDAQ: BIVN) today announced that the Company will host a conference call with the financial community to discuss the CHMP positive opinion of clofarabine on February 24th at 8 a.m. EST. To participate in the live call by telephone, please dial 877-825-5811 from the U.S. and Canada or 973-582-2767 from outside the U.S. A telephone replay of the call will be available beginning at 10 a.m. EST February 24th until 11:59 p.m. EST March 5th by dialing 877-519-4471 or 973-341-3080 and entering reservation number 7086938.
